HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
EMC1
ER membrane protein complex subunit 1
Chromosome 1 Β· 1p36.13
NCBI Gene: 23065Ensembl: ENSG00000127463.16HGNC: HGNC:28957UniProt: H7C5A2
114PubMed Papers
21Diseases
0Drugs
99Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
membrane insertase activityprotein bindingprotein insertion into ER membrane by stop-transfer membrane-anchor sequencetail-anchored membrane protein insertion into ER membranecerebellar atrophy, visual impairment, and psychomotor retardation;hypotonia, infantile, with psychomotor retardation and characteristic faciesgenetic disorderRetinal dystrophy
✦AI Summary

EMC1 is a core subunit of the endoplasmic reticulum membrane protein complex (EMC) that functions as a membrane protein insertase and chaperone 1. EMC1 mediates energy-independent insertion of newly synthesized membrane proteins into the ER membrane, with particular capacity for proteins containing weakly hydrophobic transmembrane domains or destabilizing features 2. The protein facilitates both cotranslational insertion of multipass membrane proteins and post-translational insertion of tail-anchored proteins, controlling proper N-exo topology critical for G protein-coupled receptor function 3. Mechanistically, EMC1 engages transmembrane domains and modulates their orientation within the lipid bilayer during productive assembly 1. EMC1 mutations cause significant clinical disease. Biallelic variants lead to neurodevelopmental delay, cerebellar atrophy, and visual impairment 4, while de novo monoallelic variants also cause neurodevelopmental delay, seizures, and cerebellar degeneration with glial-specific vulnerability 4. EMC1 mutations are associated with retinal degenerationβ€”Emc1 knockout in photoreceptors recapitulates retinitis pigmentosa phenotypes through mislocalization of rhodopsin and progressive rod and cone degeneration 5. EMC1 variants additionally contribute to congenital heart disease and craniofacial malformations through disrupted neural crest cell development and impaired WNT signaling 6. The gene represents both a membrane protein biogenesis factor and a novel disease locus for inherited neurological and retinal conditions.

Sources cited
1
EMC1 enables energy-independent insertion of membrane proteins with weakly hydrophobic transmembrane domains and post-translational insertion of tail-anchored proteins
PMID: 29242231
2
EMC1 mediates cotranslational insertion of multipass membrane proteins and controls N-exo topology of GPCRs
PMID: 30415835
3
EMC1 functions as a chaperone that engages transmembrane domains and modulates their orientation in the lipid bilayer
PMID: 40753078
4
De novo EMC1 variants cause neurodevelopmental delay, cerebellar degeneration, and visual impairment; glial dosage of EMC1 is particularly critical
PMID: 35234901
5
Emc1 deletion in photoreceptors causes retinitis pigmentosa phenotypes with rhodopsin mislocalization and progressive rod/cone degeneration
PMID: 37098815
6
EMC1 is necessary for neural crest development and WNT signaling; mutations cause congenital heart disease and craniofacial malformations
PMID: 31904590
7
EMC1 was identified as a novel candidate disease gene for retinal dystrophy through exome sequencing
PMID: 23105016
Disease Associationsβ“˜21
cerebellar atrophy, visual impairment, and psychomotor retardation;Open Targets
0.77Strong
hypotonia, infantile, with psychomotor retardation and characteristic faciesOpen Targets
0.55Moderate
genetic disorderOpen Targets
0.50Moderate
Retinal dystrophyOpen Targets
0.49Moderate
Global developmental delayOpen Targets
0.41Moderate
Cerebellar atrophyOpen Targets
0.41Moderate
global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndromeOpen Targets
0.37Weak
autosomal recessive retinitis pigmentosaOpen Targets
0.33Weak
congenital anomaly of kidney and urinary tractOpen Targets
0.27Weak
congenital hydronephrosisOpen Targets
0.27Weak
obesityOpen Targets
0.26Weak
complex neurodevelopmental disorder with motor featuresOpen Targets
0.23Weak
retinitis pigmentosaOpen Targets
0.12Weak
microcephalyOpen Targets
0.11Weak
hepatocellular carcinomaOpen Targets
0.07Suggestive
infectionOpen Targets
0.03Suggestive
Familial exudative vitreoretinopathyOpen Targets
0.02Suggestive
neoplasmOpen Targets
0.02Suggestive
cancerOpen Targets
0.01Suggestive
scoliosisOpen Targets
0.01Suggestive
Cerebellar atrophy, visual impairment, and psychomotor retardationUniProt
Pathogenic Variants99
NM_015047.3(EMC1):c.808dup (p.Ser270fs)Pathogenic
not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 270
NM_015047.3(EMC1):c.245C>T (p.Thr82Met)Pathogenic
Cerebellar atrophy, visual impairment, and psychomotor retardation;|not specified|not provided|Inborn genetic diseases|EMC1-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 82
NM_015047.3(EMC1):c.797T>G (p.Leu266Ter)Pathogenic
not provided|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 266
NM_015047.3(EMC1):c.1978C>T (p.Arg660Ter)Pathogenic
not provided|Cerebellar atrophy, visual impairment, and psychomotor retardation;
β˜…β˜…β˜†β˜†2025β†’ Residue 660
NM_015047.3(EMC1):c.2722C>T (p.Arg908Ter)Pathogenic
not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 908
NM_015047.3(EMC1):c.1806T>G (p.Tyr602Ter)Pathogenic
not provided|Cerebellar atrophy, visual impairment, and psychomotor retardation;
β˜…β˜…β˜†β˜†2025β†’ Residue 602
NM_015047.3(EMC1):c.205C>T (p.Arg69Ter)Pathogenic
not provided|Retinal dystrophy|Cerebellar atrophy, visual impairment, and psychomotor retardation;
β˜…β˜…β˜†β˜†2025β†’ Residue 69
NM_015047.3(EMC1):c.2675_2676delPathogenic
not provided|Cerebellar atrophy, visual impairment, and psychomotor retardation;
β˜…β˜…β˜†β˜†2025
NM_015047.3(EMC1):c.2059C>T (p.Arg687Ter)Pathogenic
not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 687
NM_015047.3(EMC1):c.2216del (p.Asn739fs)Pathogenic
not provided|Cerebellar atrophy, visual impairment, and psychomotor retardation;
β˜…β˜…β˜†β˜†2025β†’ Residue 739
NM_015047.3(EMC1):c.2619_2622del (p.Pro874fs)Pathogenic
Cerebellar atrophy, visual impairment, and psychomotor retardation;|not provided|Congenital anomaly of kidney and urinary tract
β˜…β˜…β˜†β˜†2025β†’ Residue 874
NM_015047.3(EMC1):c.426C>A (p.Tyr142Ter)Pathogenic
not provided|Cerebellar atrophy, visual impairment, and psychomotor retardation;
β˜…β˜…β˜†β˜†2024β†’ Residue 142
NM_015047.3(EMC1):c.1134C>A (p.Tyr378Ter)Pathogenic
Global developmental delay;Cerebellar atrophy|not provided
β˜…β˜…β˜†β˜†2023β†’ Residue 378
NM_015047.3(EMC1):c.287-1G>ALikely pathogenic
not provided|Cerebellar atrophy, visual impairment, and psychomotor retardation;
β˜…β˜…β˜†β˜†2023
NM_015047.3(EMC1):c.787-1G>ALikely pathogenic
not provided|Cerebellar atrophy, visual impairment, and psychomotor retardation;
β˜…β˜…β˜†β˜†2022
NM_015047.3(EMC1):c.2T>G (p.Met1Arg)Pathogenic
Cerebellar atrophy, visual impairment, and psychomotor retardation;|not provided
β˜…β˜…β˜†β˜†2021β†’ Residue 1
NM_015047.3(EMC1):c.313C>T (p.Arg105Ter)Pathogenic
Obesity|not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 105
NM_015047.3(EMC1):c.1744C>T (p.Pro582Ser)Likely pathogenic
Cerebellar atrophy, visual impairment, and psychomotor retardation;
β˜…β˜†β˜†β˜†2025β†’ Residue 582
NM_015047.3(EMC1):c.1429del (p.Ala477fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 477
NM_015047.3(EMC1):c.1617_1632+6delLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2025
View on ClinVar β†—
Related Genes
EMC8Protein interaction100%EMC9Protein interaction100%EMC4Protein interaction100%EMC7Protein interaction100%DDOSTProtein interaction100%DERL1Protein interaction99%
Tissue Expression6 tissues
Brain
100%
Heart
61%
Ovary
56%
Liver
48%
Lung
48%
Bone Marrow
36%
Gene Interaction Network
Click a node to explore
EMC1EMC8EMC9EMC4EMC7DDOSTDERL1
PROTEIN STRUCTURE
Preparing viewer…
PDB8J0O Β· 3.32 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.91LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.77 [0.65–0.91]
RankingsWhere EMC1 stands among ~20K protein-coding genes
  • #4,145of 20,598
    Most Researched114 Β· top quartile
  • #784of 5,498
    Most Pathogenic Variants99 Β· top quartile
  • #8,337of 17,882
    Most Constrained (LOEUF)0.91
Genes detectedEMC1
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
PMID: 20301590
1.00
2
Autozygome-guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes.
PMID: 23105016
Genome Res Β· 2013
0.90
3
ECM1 Prevents Activation of Transforming Growth Factor Ξ², Hepatic Stellate Cells, and Fibrogenesis in Mice.
PMID: 31362006
Gastroenterology Β· 2019
0.80
4
Deletion of Emc1 in photoreceptor cells causes retinal degeneration in mice.
PMID: 37098815
FEBS J Β· 2023
0.70
5
Mechanisms Underlying Rare Inherited Pediatric Retinal Vascular Diseases: FEVR, Norrie Disease, Persistent Fetal Vascular Syndrome.
PMID: 37947657
Cells Β· 2023
0.60